Martin Aepfelbacher
Overview
Explore the profile of Martin Aepfelbacher including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
168
Citations
7134
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Olearo F, Schoppmeier C, Both A, Citak M, Maschkowitz G, Schubert S, et al.
Eur J Clin Microbiol Infect Dis
. 2025 Feb;
PMID: 39998794
Pathogen identification is key to the management of periprosthetic joint infection (PJI). Staphylococcus epidermidis is a major cause of PJI. Differentiating between invasive and contaminating S. epidermidis from joint specimens...
2.
Berinson B, Tanida K, Spenke L, Krivec L, Keller J, Rolvien T, et al.
Microbiol Spectr
. 2025 Feb;
:e0223924.
PMID: 39998242
Limitations of culture-based diagnostic approaches in pathogen detection in joint infections (JI) can be overcome by amplification-based, molecular assays. Recently, a syndromic panel PCR (spPCR) assay (Biofire JI panel; BJA)...
3.
Weisselberg S, Both A, Failla A, Huang J, Linder S, Ohnezeit D, et al.
NPJ Biofilms Microbiomes
. 2024 Nov;
10(1):131.
PMID: 39567551
Biofilm formation shields Staphylococcus epidermidis from host defense mechanisms, contributing to chronic implant infections. Using wild-type S. epidermidis 1457, a PIA-negative mutant (1457-M10), and an eDNA-negative mutant (1457ΔatlE), this study...
4.
Olearo F, Christner M, Lutgehetmann M, Aepfelbacher M, Fischer N, Rohde H
Clin Microbiol Infect
. 2024 Nov;
PMID: 39550030
No abstract available.
5.
Pfefferle S, Schweizer M, Hartmann K, Berger J, Norz D, Emmerich P, et al.
Heliyon
. 2024 Oct;
10(19):e38873.
PMID: 39444396
Objectives: We report prolonged mpox (>14 weeks) in a patient with HIV complicated by deep tissue MPXV infection despite two courses of tecovirimat treatment. Methods: MPXV-DNA levels in lesional swabs,...
6.
Hannemann J, Zink A, Mileva Y, Balfanz P, Dahl E, Volland S, et al.
Sci Rep
. 2024 Jul;
14(1):15739.
PMID: 38977837
Mortality of patients hospitalized with COVID-19 has remained high during the consecutive SARS-CoV-2 pandemic waves. Early discrimination of patients at high mortality risk is crucial for optimal patient care. Symmetric...
7.
Prester A, Perbandt M, Galchenkova M, Oberthuer D, Werner N, Henkel A, et al.
Commun Chem
. 2024 Jul;
7(1):152.
PMID: 38969718
The emergence and spread of antibiotic resistance represent a growing threat to public health. Of particular concern is the appearance of β-lactamases, which are capable to hydrolyze and inactivate the...
8.
Tang H, Norz D, Grunwald M, Giersch K, Pfefferle S, Fischer N, et al.
J Clin Virol
. 2024 May;
173:105693.
PMID: 38820916
Background: Viral respiratory Infections pose a health risk, especially to vulnerable patient populations. Effective testing programs can detect and differentiate these infections at an early stage, which is particularly important...
9.
Carsten A, Failla A, Aepfelbacher M
J Microsc
. 2024 Apr;
PMID: 38661499
Since its introduction in 2017, MINFLUX nanoscopy has shown that it can visualise fluorescent molecules with an exceptional localisation precision of a few nanometres. In this overview, we provide a...
10.
Giersch K, Tanida K, Both A, Norz D, Heim D, Rohde H, et al.
Sci Rep
. 2024 Feb;
14(1):3523.
PMID: 38347048
Vancomycin resistant enterococci (VRE) are a leading cause of ICU-acquired bloodstream infections in Europe. The bacterial load in enteral colonization may be associated with a higher probability of transmission. Here,...